Ultomiris 300 MG/3 ML vial 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9KX7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,820
Award facts
- Contract value 100% obligated
- $30,820.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30.8K firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Ultomiris (pegcetacoplan) 300 mg/3 mL vials. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $1 billion through December 2026, which serves as a comprehensive global pharmaceutical supply vehicle for military healthcare systems. The contract involves no set-aside designation and was competitively awarded, with a completion date of February 4, 2026. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen, operating as a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. The company's extensive portfolio of federal contracts demonstrates capability in supplying specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical devices to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The Ultomiris delivery order supports the Defense Health Agency and broader military healthcare operations, fulfilling critical medical supply requirements through the established IDC vehicle that enables flexible and efficient procurement of pharmaceutical commodities worldwide.
Quick answers
Who was awarded contract SPE2DR26F9KX7?
SPE2DR26F9KX7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F9KX7 worth?
The government has obligated $30,820 on SPE2DR26F9KX7.
Is contract SPE2DR26F9KX7 an order under another contract?
Yes. SPE2DR26F9KX7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KX7 competed?
The extent of competition for SPE2DR26F9KX7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award